INHIBITION OF NEUROPILIN-2 TO ENHANCE IMMUNOTHERAPY OF LETHAL PROSTATE CANCER

$433,258FY2021Defense Health AgencyDOD

University Of Massachusetts Medical School, Worcester MA

Investigators